AHRQ Patient Safety Network ► SIMMEON-Prep study: SIMulation of Medication Errors in ONcology: prevention of antineoplastic preparation errors.

AHRQ Patient Safety Network





SIMMEON-Prep study: SIMulation of Medication Errors in ONcology: prevention of antineoplastic preparation errors.

Sarfati L, Ranchon F, Vantard N, et al. J Clin Pharm Ther. 2014 Oct 18; [Epub ahead of print].

This study examined error detection in chemotherapeutic preparation, which has been associated with several high-profile adverse outcomes. Pharmacy technicians were more likely to identify errors following asimulation exercise, adding to the evidence for simulation as an effective patient safety tool. A past AHRQ WebM&M perspective discussed a widely-publicized incident involving a patient who died due to inadvertent overdose of chemotherapy and the resulting organizational changes made in the hospital.

PubMed citation 
Available at 

Related Resources

STUDY

Do drug interaction alerts between a chemotherapy order-entry system and an electronic medical record affect clinician behavior?

Weingart SN, Zhu J, Young-Hong J, Vermilya HB, Hassett M. J Oncol Pharm Pract. 2014;20:163-171.

STUDY

Prospective risk analysis and incident reporting for better pharmaceutical care at paediatric hospital discharge.

Kaestli LZ, Cingria L, Fonzo-Christe C, Bonnabry P. Int J Clin Pharm. 2014;36:953-962.

STUDY

Chemotherapy safety and severe adverse events in cancer patients: strategies to efficiently avoid chemotherapy errors in in- and outpatient treatment.

Markert A, Thierry V, Kleber M, Behrens M, Engelhardt M. Int J Cancer. 2009;124:722-728.

REVIEW

Medication errors in chemotherapy: incidence, types and involvement of patients in prevention. A review of the literature.

Schwappach DLB, Wernli M. Eur J Cancer Care (Engl). 2009;19:285-292.

View all related resources...